Oculis Holding AG (OCS) Operating Income Growth (3y) (2025 - 2026)

Oculis Holding AG (OCS) Operating Income Growth (3y) (2025 - 2026) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Op. Inc Growth (3y) (Qtr)
1 Oculis Holding AG 66,561.01 Bn 66,560.72 Bn - 16.96%
2 Nanobiotix 1,911.11 Bn 1,911.05 Bn - -
3 Akari Therapeutics 1,009.43 Bn 1,009.43 Bn - -
4 BeOne Medicines 467.81 Bn 463.02 Bn 1.35 Bn 38.78%
5 Vertex Pharmaceuticals 122.92 Bn 115.68 Bn 2.59 Bn 13.47%
6 Regeneron Pharmaceuticals 70.28 Bn 61.53 Bn 3.31 Bn -12.10%
7 Belite Bio 62.88 Bn 62.88 Bn - -
8 Argenx Se 55.90 Bn 50.72 Bn 1.41 Bn 69.02%
9 Alnylam Pharmaceuticals 37.53 Bn 34.52 Bn 959.66 Mn 55.96%
10 Revolution Medicines 37.38 Bn 37.38 Bn - -

Historic Data

Download Data
DateValue
Mar 31, 2026 16.96%
Dec 31, 2025 -30.80%
Sep 30, 2025 84.72%
Jun 30, 2025 -37.78%